Re-Export of Heparin for Therapeutic Use

This key economic indicator for the Pharmaceutical sector has been recently updated.

  1. Canada Re-Export of Heparin for Therapeutic Use was up 95.1% in 2019, compared to a year earlier.
  2. Since 2014 New Zealand Re-Export of Heparin for Therapeutic Use jumped by 141.8% year on year reaching $90,204.13.
  3. In 2019 Canada was ranked number 2 in Re-Export of Heparin for Therapeutic Use.
  4. In 2018 Cyprus was ranked number 9 in Re-Export of Heparin for Therapeutic Use attaining $10,187.59, moving from 11 in 2017.

Top Countries in Re-Export of Heparin for Therapeutic Use

# 11 Countries US Dollars Last YoY 5‑years CAGR
1 #1
United States
4,598,060.57 2019 -5.2 % -29.7 % View data
2 #2
Canada
1,368,644.83 2019 +95.1 % +28.6 % View data
3 #3
Barbados
212,328.10 2019 +12.0 % +14.6 % View data
4 #4
Saudi Arabia
173,620.88 2016 -45.1 % NA View data
5 #5
Jordan
114,511.44 2019 -6.3 % -22.7 % View data
6 #6
New Zealand
90,204.13 2019 -3.7 % +141.8 % View data
7 #7
United Arab Emirates
46,048.80 2019 -14.7 % +23.1 % View data
8 #8
Georgia
30,743.97 2014 +1,069.4 % +221.2 % View data
9 #9
Cyprus
10,187.59 2018 NA NA View data
10 #10
Moldova
2,072.00 2017 +67.6 % NA View data
11 #11
Bahrain
712.55 2017 +9.0 % NA View data

Source: United Nations Statistical Office

Go Top